Scintigraphy in rheumatic diseases.

Abstract

The aim of this review is to summarise the clinical role of nuclear medicine in rheumatology taking into consideration the most specific diagnostic applications and other worthwhile therapeutic contributions. Traditional bone scintigraphy and recent inflammation-targeting radiopharmaceuticals, such as radiolabelled leucocytes and immunoscintigraphy, now allow us to obtain highly sensitive total-body and tomographical imaging information that can be used for the diagnosis of osteoarticular disease. The most common extra-articular manifestations of rheumatic diseases due to digestive, central nervous, respiratory and cardiovascular system involvement can be diagnosed by specific scintigraphic methods. Radiosynovectomy plays an important role in providing effective treatment for some joint diseases that are resistant to pharmacological therapy. Diagnostic and therapeutic applications of nuclear medicine show the highest efficacy in the early phase of rheumatic diseases. In more advanced stages, scintigraphical techniques play a complementary role to radiographical investigations in the assessment of prognosis and therapy efficacy.

• Authors: Paolo Colamussi, Napoleone Prandini, Corrado Cittanti, Luciano Feggi, Melchiore Giganti
• Journal: Best practice & research. Clinical rheumatology (Best Pract Res Clin Rheumatol) Vol. 18 Issue 6 Pg. 909-26 (Dec 2004) ISSN: 1521-6942 [Print] Netherlands
• PMID: 15501189 (Publication Type: Journal Article, Review)

Chemical References

• Radioisotopes
• Radiopharmaceuticals

Topics

• Humans
• Radioisotopes (therapeutic use)
• Radionuclide Imaging (methods)
• Radiopharmaceuticals (therapeutic use)
• Rheumatic Diseases (complications, diagnostic imaging, radiotherapy)
• Rheumatology (methods)
• Synovial Membrane (pathology, radiation effects)
• Synovitis (complications, radiotherapy)